Clinical Trials Logo

Male Osteoporosis clinical trials

View clinical trials related to Male Osteoporosis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00439647 Completed - Male Osteoporosis Clinical Trials

Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis

Start date: December 2006
Phase: Phase 3
Study type: Interventional

This study will investigate if the drug zoledronic acid given once yearly is safe and has beneficial effects in treating osteoporosis by reducing bone loss and fractures in men with osteoporosis.

NCT ID: NCT00397839 Completed - Male Osteoporosis Clinical Trials

The Effect Of Oral Ibandronate In Male Osteoporosis

STRONG
Start date: January 2007
Phase: Phase 3
Study type: Interventional

Male osteoporosis is a common and important clinical problem, associated with significant morbidity, mortality and societal expense. Approximately 10% of men =65 years of age are osteoporotic. The proposed study will evaluate efficacy and safety of oral ibandronate given 150 mg once-monthly for 12 months versus placebo in men with primary osteoporosis. Less frequent, once monthly, dosing is expected to improve patient's treatment adherence compared to a weekly dosing regimen.